Imagine a fleet of microscopic machines cruising through your body, vacuuming up dangerous bacteria, and then dropping them off at a designated location on demand. This is no longer a sci-fi movie scenario. Researchers have just unveiled ultra-fast, light-driven nanorobots that could revolutionize medicine and the way we deliver drugs.
Surgical robots are already part of modern medicine, but few people seem to realize it. The paradox is that the technology is advancing rapidly: new platforms, digital ecosystems, early clinical telesurgery protocols, and even laboratory demonstrations of partial autonomy are all emerging at once. Yet when you step into a hospital, things often look much the same as they did 5 to 10 years ago. Economics, regulation, and organizational barriers are a big part of the reason.
Israeli firm ForSight Robotics has announced the successful completion of the first-ever fully robotic cataract surgery on a human patient. The procedure was performed without the need for general anesthesia, a breakthrough that could radically shift global standards and accessibility in ophthalmic care.
Researchers at UC Berkeley have built an “organ-on-a-chip” system that can replicate up to 40 years of human tissue aging in just four days. The technology could speed up the development of anti-aging therapies.
The U.S. FDA has released new guidance for medical devices aimed at weight loss, laying out stricter requirements for clinical trials, effectiveness, and safety.
BrightGene has reported positive Phase 1 results for BGM0504, an oral obesity drug. The treatment is designed to work like GLP-1 therapies – but without injections.
In May 2026, Las Vegas is set to host the inaugural Enhanced Games — a competition its organizers pitch as an alternative to traditional sports. The concept is as simple as it is explosive: athletes will be permitted to compete using substances and methods banned under anti-doping rules, but, according to the project’s creators, under medical supervision and in a fully transparent framework. The official website lists May 24, 2026 as the opening date. The program includes swimming, athletics, and weightlifting.
New research suggests that semaglutide – the active compound in drugs such as Ozempic and Wegovy – may help reverse tissue changes in osteoarthritis rather than merely reducing pain or improving joint function. This could represent a significant shift in understanding how this class of drugs works, extending beyond its established use in diabetes and obesity treatment.
Robot-assisted surgery is still perceived as “the future is here,” a hallmark of high-tech medicine, and is on the verge of becoming routine practice. In eye microsurgery, where microscopic precision of movements is critical, robotic surgical assistants are often indispensable. But now Chinese medical researchers have developed and begun testing a robot capable of performing intraocular surgeries autonomously. Soon, we may face a situation where the human surgeon doesn’t control the robot-surgeon at all, but simply observes. Who will bear responsibility for the surgical outcome? Isn’t the risk too high?
Artificial intelligence is beginning to outperform humans in narrow but economically consequential tasks, raising anxieties about job security and even agency. We are seriously discussing the possibility of losing control over AI. And one of the proposed ways of dealing with it is integration: linking the nervous system to digital tools through the brain-computer interfaces (BCIs).